Bioassays
Promega provides a comprehensive range of reporter cell based bioassays, essential for developing innovative monoclonal antibody (mAb) therapies and cell-based treatments. These bioassays are crucial for examining various biological processes, such as Fc effector functions, modulation of immune checkpoints, activation of T cells, and signaling of cytokines and growth factors.
Our constantly evolving collection of bioassays is characterized by their quantitative accuracy and precision. We collaborate closely with drug developers during the initial phases of biologic therapy development, ensuring that our bioassays align with your specific requirements.
- Bioassays can play a pivotal role in pharmaceutical development, offering vital information about the potency and stability of drug products.
- They are integral in monitoring manufacturing quality, conducting lot release tests, and establishing dose-response relationships to determine safe and effective drug levels.
- Bioassays are instrumental in verifying the similarity between original drugs and their biosimilar counterpart.
- Our high-quality bioassay are dependable, standardized, and accurately reflects the mechanism of action of the drug being tested.
Related Products
SIRPα/CD47 Blockade Bioassay, Fc-Dependent
Evaluate Potency and Stability of biologics in Blocking SIRPα/CD47 Interactions
Conforms to ICH guidelines for stability indication
Offered in 96- and 384-well plate formats
No need for primary cell culture
SIRPα/CD47 Blockade Bioassay
Test the potency and Stability of Biologics in ADCP Activation via FcγRs
Media
See AllFor More Information
Intrested in a specific Product? let us Know how we can help you.
Stay Updated
